Desselberger Ulrich
Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
Pathogens. 2018 Jun 21;7(3):57. doi: 10.3390/pathogens7030057.
The mammalian gut is colonized by a large variety of microbes, collectively termed ‘the microbiome’. The gut microbiome undergoes rapid changes during the first few years of life and is highly variable in adulthood depending on various factors. With the gut being the largest organ of immune responses, the composition of the microbiome of the gut has been found to be correlated with qualitative and quantitative differences of mucosal and systemic immune responses. Animal models have been very useful to unravel the relationship between gut microbiome and immune responses and for the understanding of variations of immune responses to vaccination in different childhood populations. However, the molecular mechanisms underlying optimal immune responses to infection or vaccination are not fully understood. The gut virome and gut bacteria can interact, with bacteria facilitating viral infectivity by different mechanisms. Some gut bacteria, which have a beneficial effect on increasing immune responses or by overgrowing intestinal pathogens, are considered to act as probiotics and can be used for therapeutic purposes (as in the case of fecal microbiome transplantation).
哺乳动物的肠道被大量微生物所定植,这些微生物统称为“微生物组”。肠道微生物组在生命的最初几年会经历快速变化,在成年期则因各种因素而高度可变。由于肠道是免疫反应的最大器官,已发现肠道微生物组的组成与黏膜和全身免疫反应的质和量的差异相关。动物模型对于揭示肠道微生物组与免疫反应之间的关系以及理解不同儿童群体对疫苗接种的免疫反应变化非常有用。然而,对感染或疫苗接种产生最佳免疫反应的分子机制尚未完全了解。肠道病毒组和肠道细菌可以相互作用,细菌通过不同机制促进病毒感染性。一些对增强免疫反应或通过过度生长肠道病原体具有有益作用的肠道细菌被认为是益生菌,可用于治疗目的(如粪便微生物组移植的情况)。